Table 3.
Model 1 | Model 2 | Model 3 | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | (95% CI) | p Value | OR | (95% CI) | p Value | OR | (95% CI) | p Value | |
Age, 0.1 year | 1.00 | (0.99–1.07) | 0.63 | 1.00 | (0.98–1.02) | 0.97 | 1.001 | (0.98–1.02) | 0.97 |
Sex, male | 0.63 | (0.39–1.07) | 0.09 | 0.73 | (0.42–1.26) | 0.25 | 0.682 | (0.42–1.26) | 0.25 |
BMI, 0.1 | 1.05 | (0.98–1.02) | 0.15 | 1.05 | (0.98–1.12) | 0.14 | 1.054 | (0.98–1.12) | 0.14 |
Care bundle intervention | 0.30 | (0.17–0.51) | 0.01* | 0.36 | (0.20–0.64) | 0.01* | 0.357 | (0.20–0.64) | 0.01* |
Hyperosmolar solutions | 3.12 | (1.74–5.57) | 0.01* | ||||||
C-reactive protein, 0.1 mg/dL | 1.06 | (1.00–1.12) | 0.04* | 1.06 | (1.00–1.12) | 0.05* | |||
Total un-used time (rocked time), 0.1 h | 0.99 | (0.99–1.00) | 0.09 | 0.992 | (0.99–1.00) | 0.03* | |||
Insertion anatomical site (compared with another site) | 4.17 | (1.79–9.70) | 0.01* | 4.081 | (1.76–9.45) | 0.01* | |||
Number of catheterizations | 1.462 | (0.85–2.50) | 0.17 | ||||||
Nagelkerke, R2 | 0.09 | 0.22 | 0.18 |
Hierarchical multiple logistic regression analysis was performed. Model 1 included age, sex, BMI, and care bundle intervention. Model 2 included Model 1 and hyperosmolar solutions, C-reactive protein, total un-used time, and insertion anatomical site (compared with another site). Model 3 included Model 1 and C-reactive protein, total unused time, and insertion anatomical site (compared with another site) and number of catheterizations.
OR: odds ratio. Model 3: Hosmer-Lemeshow test, p = 0.603.